Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future
Chimeric antigen receptor (CAR) T-cell therapy is the new standard treatment for various indications in patients with advanced hematologic malignancies. Despite the several preclinical and early phase clinical trials, the overall clinical experience has been disappointing when applying this innovati...
Shranjeno v:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Innovative Healthcare Institute
2023-01-01
|
| Serija: | Journal of Immunotherapy and Precision Oncology |
| Teme: | |
| Online dostop: | https://jipo.org/doi/pdf/10.36401/JIPO-22-7 |
| Oznake: |
Brez oznak, prvi označite!
|